Meeker David P
President And CEO
Sale
Calculated transaction value
$3.15M
30,746 shares @ $102.35
Traded
Sep 14, 2026
Filed
Sep 14, 2026
You're reading the free version. Trader adds the live tape and alerts.
Start tracking
Rhythm Pharmaceuticals
RYTM
ManufacturingChemicals
Transactions reported in official disclosures
Price with disclosed trades
Daily closes, past year · marks sit on transaction dates, sized by value
60 trades
| Reporting person | Filed | Transaction | Transaction value | Source | Actions |
|---|---|---|---|---|---|
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Sale Sep 14, 2026 | $3.15M Filed shares x price | SEC Form 4 View filing | |
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Exercise Sep 14, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Sale Sep 14, 2026 | $899.63K Filed shares x price | SEC Form 4 View filing | |
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Sale Sep 14, 2026 | $241.94K Filed shares x price | SEC Form 4 View filing | |
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Exercise Sep 14, 2026 | $302.5K Filed shares x price | SEC Form 4 View filing | |
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Sale Sep 14, 2026 | $189.96K Filed shares x price | SEC Form 4 View filing | |
| Meeker David P President And CEO | Sep 14, 2026 Same-day filing | Sale Sep 14, 2026 | $655.15K Filed shares x price | SEC Form 4 View filing | |
| Smith Hunter C Chief Financial Officer | Sep 1, 2026 1-day lag | Sale Aug 31, 2026 | $1.21M Filed shares x price | SEC Form 4 View filing | |
| Smith Hunter C Chief Financial Officer | Sep 1, 2026 1-day lag | Sale Aug 31, 2026 | $2.99M Filed shares x price | SEC Form 4 View filing | |
| Smith Hunter C Chief Financial Officer | Sep 1, 2026 1-day lag | Exercise Aug 31, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Smith Hunter C Chief Financial Officer | Sep 1, 2026 1-day lag | Sale Aug 31, 2026 | $2.41M Filed shares x price | SEC Form 4 View filing | |
| Smith Hunter C Chief Financial Officer | Sep 1, 2026 1-day lag | Exercise Aug 31, 2026 | $1.47M Filed shares x price | SEC Form 4 View filing | |
| Joshi Manher Chief Medical Officer | Aug 18, 2026 1-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Joshi Manher Chief Medical Officer | Aug 18, 2026 1-day lag | Award Aug 17, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Shulman Joseph Chief Technical Officer | Aug 17, 2026 4-day lag | Exercise Aug 13, 2026 | $13.76K Filed shares x price | SEC Form 4 View filing | |
| Shulman Joseph Chief Technical Officer | Aug 17, 2026 4-day lag | Exercise Aug 13, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Shulman Joseph Chief Technical Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $608.21K Filed shares x price | SEC Form 4 View filing | |
| Garfield Alastair Chief Scientific Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $233.03K Filed shares x price | SEC Form 4 View filing | |
| Garfield Alastair Chief Scientific Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $95.34K Filed shares x price | SEC Form 4 View filing | |
| Garfield Alastair Chief Scientific Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $182.17K Filed shares x price | SEC Form 4 View filing | |
| Garfield Alastair Chief Scientific Officer | Aug 17, 2026 4-day lag | Sale Aug 13, 2026 | $402.17K Filed shares x price | SEC Form 4 View filing | |
| Lee Jennifer Kayden EVP, Head Of North America | Aug 14, 2026 1-day lag | Exercise Aug 13, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lee Jennifer Kayden EVP, Head Of North America | Aug 14, 2026 1-day lag | Sale Aug 13, 2026 | $8.9M Filed shares x price | SEC Form 4 View filing | |
| Lee Jennifer Kayden EVP, Head Of North America | Aug 14, 2026 1-day lag | Exercise Aug 13, 2026 | $0 Filed shares x price | SEC Form 4 View filing | |
| Lee Jennifer Kayden EVP, Head Of North America | Aug 14, 2026 1-day lag | Exercise Aug 13, 2026 | $850.15K Filed shares x price | SEC Form 4 View filing | |
| Lee Jennifer Kayden EVP, Head Of North America | Aug 14, 2026 1-day lag | Exercise Aug 13, 2026 | $146.89K Filed shares x price | SEC Form 4 View filing | |
| Mazabraud Yann EVP, Head Of International | Aug 14, 2026 2-day lag | Sale Aug 12, 2026 | $112.86K Filed shares x price | SEC Form 4 View filing | |
| Mazabraud Yann EVP, Head Of International | Aug 14, 2026 2-day lag | Sale Aug 12, 2026 | $2.03M Filed shares x price | SEC Form 4 View filing | |
| Mazabraud Yann EVP, Head Of International | Aug 14, 2026 2-day lag | Sale Aug 12, 2026 | $413.48K Filed shares x price | SEC Form 4 View filing | |
| Mazabraud Yann EVP, Head Of International | Aug 14, 2026 2-day lag | Sale Aug 12, 2026 | $257.14K Filed shares x price | SEC Form 4 View filing |
Meeker David P
President And CEO
Exercise
Calculated transaction value
$0
50,000 shares @ $0
Traded
Sep 14, 2026
Filed
Sep 14, 2026
Meeker David P
President And CEO
Sale
Calculated transaction value
$899.63K
8,698 shares @ $103.43
Traded
Sep 14, 2026
Filed
Sep 14, 2026
Meeker David P
President And CEO
Sale
Calculated transaction value
$241.94K
2,300 shares @ $105.19
Traded
Sep 14, 2026
Filed
Sep 14, 2026
Meeker David P
President And CEO
Exercise
Calculated transaction value
$302.5K
50,000 shares @ $6.05
Traded
Sep 14, 2026
Filed
Sep 14, 2026
Meeker David P
President And CEO
Sale
Calculated transaction value
$189.96K
1,817 shares @ $104.55
Traded
Sep 14, 2026
Filed
Sep 14, 2026
Meeker David P
President And CEO
Sale
Calculated transaction value
$655.15K
6,439 shares @ $101.75
Traded
Sep 14, 2026
Filed
Sep 14, 2026
Smith Hunter C
Chief Financial Officer
Sale
Calculated transaction value
$1.21M
11,514 shares @ $105.37
Traded
Aug 31, 2026
Filed
Sep 1, 2026
Smith Hunter C
Chief Financial Officer
Sale
Calculated transaction value
$2.99M
28,188 shares @ $106.2
Traded
Aug 31, 2026
Filed
Sep 1, 2026
Smith Hunter C
Chief Financial Officer
Exercise
Calculated transaction value
$0
57,187 shares @ $0
Traded
Aug 31, 2026
Filed
Sep 1, 2026
Smith Hunter C
Chief Financial Officer
Sale
Calculated transaction value
$2.41M
23,072 shares @ $104.59
Traded
Aug 31, 2026
Filed
Sep 1, 2026
Smith Hunter C
Chief Financial Officer
Exercise
Calculated transaction value
$1.47M
57,187 shares @ $25.79
Traded
Aug 31, 2026
Filed
Sep 1, 2026
Joshi Manher
Chief Medical Officer
Award
Calculated transaction value
$0
25,000 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Joshi Manher
Chief Medical Officer
Award
Calculated transaction value
$0
50,000 shares @ $0
Traded
Aug 17, 2026
Filed
Aug 18, 2026
Shulman Joseph
Chief Technical Officer
Exercise
Calculated transaction value
$13.76K
2,024 shares @ $6.8
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Shulman Joseph
Chief Technical Officer
Exercise
Calculated transaction value
$0
2,024 shares @ $0
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Shulman Joseph
Chief Technical Officer
Sale
Calculated transaction value
$608.21K
5,079 shares @ $119.75
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Garfield Alastair
Chief Scientific Officer
Sale
Calculated transaction value
$233.03K
2,007 shares @ $116.11
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Garfield Alastair
Chief Scientific Officer
Sale
Calculated transaction value
$95.34K
800 shares @ $119.17
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Garfield Alastair
Chief Scientific Officer
Sale
Calculated transaction value
$182.17K
1,556 shares @ $117.08
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Garfield Alastair
Chief Scientific Officer
Sale
Calculated transaction value
$402.17K
3,400 shares @ $118.28
Traded
Aug 13, 2026
Filed
Aug 17, 2026
Lee Jennifer Kayden
EVP, Head Of North America
Exercise
Calculated transaction value
$0
35,000 shares @ $0
Traded
Aug 13, 2026
Filed
Aug 14, 2026
Lee Jennifer Kayden
EVP, Head Of North America
Sale
Calculated transaction value
$8.9M
75,834 shares @ $117.38
Traded
Aug 13, 2026
Filed
Aug 14, 2026
Lee Jennifer Kayden
EVP, Head Of North America
Exercise
Calculated transaction value
$0
21,601 shares @ $0
Traded
Aug 13, 2026
Filed
Aug 14, 2026
Lee Jennifer Kayden
EVP, Head Of North America
Exercise
Calculated transaction value
$850.15K
35,000 shares @ $24.29
Traded
Aug 13, 2026
Filed
Aug 14, 2026
Lee Jennifer Kayden
EVP, Head Of North America
Exercise
Calculated transaction value
$146.89K
21,601 shares @ $6.8
Traded
Aug 13, 2026
Filed
Aug 14, 2026
Mazabraud Yann
EVP, Head Of International
Sale
Calculated transaction value
$112.86K
1,000 shares @ $112.86
Traded
Aug 12, 2026
Filed
Aug 14, 2026
Mazabraud Yann
EVP, Head Of International
Sale
Calculated transaction value
$2.03M
17,319 shares @ $117.47
Traded
Aug 12, 2026
Filed
Aug 14, 2026
Mazabraud Yann
EVP, Head Of International
Sale
Calculated transaction value
$413.48K
3,605 shares @ $114.7
Traded
Aug 12, 2026
Filed
Aug 14, 2026
Mazabraud Yann
EVP, Head Of International
Sale
Calculated transaction value
$257.14K
2,300 shares @ $111.8
Traded
Aug 12, 2026
Filed
Aug 14, 2026